It was also found that intrathecal delivery of FSLLRY-NH2 attenuated the increased expression of glutamate receptor subunits GluR1 and NR2B in the dorsal horn of the rats with bone cancer (Figure 2D). Here, GRIA1 is linked to bone cancer.